(Press-News.org) Bethesda, MD -- It's not the little blue pill famous for helping men get big results, but for those who need it, the outcome might be even more significant. A new research report published online in The FASEB Journal, offers hope to men who experience priapism. This condition, which is often seen in men with sickle cell disease, causes erections lasting so long that they cause permanent damage to the penis. Specifically, a compound, called "C6'" offered mice -- with and without sickle cell disease -- relief by normalizing nitric oxide levels in penile blood. In addition to helping men with priapism, this action of this compound also provides insight for future research related to vascular and circulatory disorders such as hypertension.
"This study has implications for quality of life by suggesting the possible role of a drug therapy for controlled, physiologic release of nitric oxide that may treat conditions of altered nitric oxide signaling or function," said Gwen Lagoda, M.S., a researcher involved in the work from the Department of Urology at Johns Hopkins Medical Institutions, in Baltimore, Maryland. "Its application may extend beyond erection disorders and include other health conditions involving abnormal circulation and blood flow."
Scientists analyzed two groups of experimental mice. The first group had both endothelial and neuronal nitric oxide synthase knocked out. The second group of mice had sickle cell disease. In both groups of mice, nitric oxide signaling was known to be abnormal and resulted in abnormal erections. When these mice were given C6' treatment, their molecular abnormalities were reduced and erectile functioning returned to levels similar to normal mice.
"Thanks to massive advertising, when people think of 'E.D.,' they often think of an inability to achieve or maintain an erection," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "What they don't realize is that there can be other problems as well. Priapism is a dangerous and painful form of erectile dysfunction that is overlooked. Hopefully this compound will be just as effective in people as it was in mice."
###
Receive monthly highlights from The FASEB Journal by e-mail. Sign up at http://www.faseb.org/fjupdate.aspx. The FASEB Journal is published by the Federation of the American Societies for Experimental Biology (FASEB). It is among the most cited biology journals worldwide according to the Institute for Scientific Information and has been recognized by the Special Libraries Association as one of the top 100 most influential biomedical journals of the past century.
FASEB is composed of 27 societies with more than 110,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.
Details: Gwen Lagoda, Sena F. Sezen, K. Joseph Hurt, Marcelo R. Cabrini, Dillip K. Mohanty, and Arthur L. Burnett. Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism. FASEB J, doi:10.1096/fj.13-228817 ; http://www.fasebj.org/content/early/2013/09/26/fj.13-228817.abstract
Beyond the little blue pill: scientists develop compound that may treat priapism
New research in The FASEB Journal suggests that C6', a compound that releases nitric oxide in the body, prevented abnormalities associated with priapism in mice with and without sickle cell disease
2013-09-30
ELSE PRESS RELEASES FROM THIS DATE:
Niacin, the fountain of youth
2013-09-30
Who would not want to live a long and healthy life? A freely available food supplement could help in this respect, scientists from ETH Zurich have demonstrated in roundworms. Vitamin B3 – also known as niacin – and its metabolite nicotinamide in the worms' diet caused them to live for about one tenth longer than usual.
As an international team of researchers headed by Michael Ristow, a professor of energy metabolism, has now experimentally demonstrated, niacin and nicotinamide take effect by promoting formation of so-called free radicals. "In roundworms, these reactive ...
Erratic proteins: New insights into a transport mechanism
2013-09-30
The outer membrane of bacteria contains many proteins that form tiny pores. They are important for absorbing nutrients and transmitting signals into the cell. The research group of Sebastian Hiller, Professor of Structural Biology at the Biozentrum, University of Basel, has now shown for the first time at atomic resolution, that these pore proteins are transported in an unstructured, constantly changing state to the outer bacterial membrane. This landmark study was recently published in the scientific journal "Nature Structural and Molecular Biology".
The cell membrane ...
Alcohol leaving the UK charts with a hangover
2013-09-30
London -- Are we allowing alcohol marketing to children and teens via the music they love? As many as one in five songs in the UK top ten today include references to alcohol -- a figure rising partly due to US-imported songs. What impact is this having on the youth of today? Experts warn that fresh evidence demonstrates that public health messages on alcohol may no longer be audible over the louder message from some sections of the music industry.
Researchers from Liverpool John Moores University, UK led by Katherine Hardcastle discuss their findings in: "Trends in alcohol ...
Trial combining anti-cancer drug and radiotherapy may lead to treatment for brain tumor
2013-09-30
Results from a clinical trial of a new treatment for glioblastoma suggest that researchers may have found a new approach to treating this most aggressive of brain tumours, as well as a potential new biological marker than can predict the tumour's response to treatment.
Presenting the research to the 2013 European Cancer Congress (ECC2013) [1] today (Monday), Professor Wolfgang Wick will say that combining radiotherapy with an anti-cancer drug called APG101 – a fusion protein similar to an antibody – blocks a cell-signalling pathway called CD95 that plays a crucial role ...
First estimate of radiotherapy dose wasted in compensating for between-treatment tumor growth
2013-09-30
For the first time, researchers have estimated the daily dose of radiotherapy that could be wasted in compensating for cancer cell growth that occurs overnight and during weekends in patients with early breast cancer.
In research to be presented to the 2013 European Cancer Congress (ECC2013) [1] today (Monday), Professor John Yarnold will say that, until now, there has been contradictory evidence as to whether gaps between radiotherapy treatments, for instance overnight or at weekends, makes any difference to the overall effectiveness of radiotherapy on breast cancer, ...
Do black holes have hair?
2013-09-30
A black hole. A simple and clear concept, at least according to the hypothesis by Roy Kerr, who in 1963 proposed a "clean" black hole model, which is the current theoretical paradigm. From theory to reality things may be quite different. According to a new research carried out by a group of scientists that includes Thomas Sotiriou, a physicist of the International School for Advanced Studies (SISSA) of Trieste, black holes may be much "dirtier" than what Kerr believed.
According to the traditional model, black holes are defined by only two quantities: mass and angular ...
The immune system benefits from life in the countryside
2013-09-30
Adults who move to farming areas where they experience a wider range of environmental exposures than in cities may reduce the symptoms of their hypersensitivities and allergies considerably. This is the result of new research from Aarhus University.
This pioneering result was recently published online in the esteemed periodical, The Journal of Allergy and Clinical Immunology in an article entitled "Become a farmer and avoid new allergic sensitization: Adult farming exposures protect against new-onset atopic sensitization".
The immune systems of people who work in farming ...
PV production grows despite a crisis-driven decline in investment
2013-09-30
Global production of photovoltaic (PV) cells grew by 10% in 2012 in comparison to 2011 despite a 9% decline in solar energy investments according to the annual "PV Status Report" released by the European Commission's Joint Research Centre. Europe remained a leader in newly installed capacities accounting for 51.7% (16.8 GW) of the 30 GW installed worldwide.
Abundant solar resources in combination with zero emissions from solar installations have attributed to PV energy systems a key role in the transition to a low carbon energy supply. This potential has driven development ...
Research shows how aspirin may act on blood platelets to improve survival in colon cancer patients
2013-09-30
Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) [1] heard today (Monday).
Although previous research has shown that taking low dose aspirin after being diagnosed with colon cancer improves patient outcome, the reasons why this happens remain unknown. The new research has shown that aspirin improves outcome in patients whose tumour cells express a specific protein on their surface; the protein is known as Human Leukocyte Antigen class I (HLA class I), a cell-surface ...
The world's sharpest X-ray beam shines at DESY
2013-09-30
The world's sharpest X-ray beam shines at DESY. At the X-ray light source PETRA III, scientists from Göttingen generated a beam with a diameter of barely 5 nanometres – this is ten thousand times thinner than a human hair. This fine beam of X-ray light allows focusing on smallest details. The research groups of Professor Tim Salditt from the Institute of X-ray Physics and of Professor Hans-Ulrich Krebs from the Institute of Materials Physics of the University of Göttingen published their work in the research journal Optics Express.
High-energy (hard) X-ray light cannot ...
LAST 30 PRESS RELEASES:
Artificial intelligence emerging as powerful patient safety tool in pediatric anesthesia
Mother’s ZIP code, lack of access to prenatal care can negatively impact baby’s health at birth, new studies show
American Society of Anesthesiologists honors John M. Zerwas, M.D., FASA, with Distinguished Service Award
A centimeter-scale quadruped piezoelectric robot with high integration and strong robustness
Study confirms that people with ADHD can be more creative. The reason may be that they let their mind wander
Research gives insight into effect of neurodegenerative diseases on speech rhythm
Biochar and plants join forces to clean up polluted soils and boost ecosystem recovery
Salk scientist Joseph Ecker awarded McClintock Prize for Plant Genetics and Genome Studies
ADHD: Women are diagnosed five years later than men, despite symptoms appearing at the same age.
Power plants may emit more pollution during government shutdowns
Increasing pressures for conformity de-skilling and demotivating teachers, study warns
Researchers develop smarter menstrual product with potential for wearable health monitoring
Microwaves for energy-efficient chemical reactions
MXene current collectors could reduce size, improve recyclability of Li-ion batteries
Living near toxic sites linked to aggressive breast cancer
New discovery could open door to male birth control
Wirth elected Fellow of American Physical Society
The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: October 10, 2025
Destined to melt
Attitudes, not income, drive energy savings at home
The playbook for perfect polaritons
‘Disease in a dish’ study of progressive MS finds critical role for unusual type of brain cell
Solar-powered method lights the way to a ‘de-fossilized’ chemical industry
Screen time linked to lower academic achievement among Ontario elementary students
One-year outcomes after traumatic brain injury and early extracranial surgery in the TRACK-TBI Study
Enduring outcomes of COVID-19 work absences on the US labor market
Affirmative action repeal and racial and ethnic diversity in us medical school admissions
Cancer progression illuminated by new multi-omics tool
Screen time and standardized academic achievement tests in elementary school
GLP-1RA order fills and out-of-pocket costs by race, ethnicity, and indication
[Press-News.org] Beyond the little blue pill: scientists develop compound that may treat priapismNew research in The FASEB Journal suggests that C6', a compound that releases nitric oxide in the body, prevented abnormalities associated with priapism in mice with and without sickle cell disease